About the Project |  FAQs |  Glossary |  Data Sources |  Bibliography |  Complete Indicator List

Indicator Details: Adjusted Incidence of Treated End Stage Renal Disease (ESRD)a,b,c
Data Sources
 
Stratification and Year Choices:
View Data By:

  Source
  • USRDS

  View Data By:
  Chart Format
  Chart Colors
Select a state from the dropdown below

State: 
County: 
Data: 





Filter By:

Sort By:




+ View Data Table
 Download Table

Footnotes:
a Adapted from the 2020 USRDS Annual Data Report (United States Renal Data System, 2020).

b For the purposes of this analysis, individuals aged 21 years or younger are considered children, while individuals aged 22 years or older are considered adults.

c Estimates are adjusted for age, race, and gender, as appropriate, using the 2015 ESRD cohort as reference.




In 2018, adjusted incidence of ESRD was dramatically higher with increasing age (>1,500 per million for people aged 75+ years compared with 139 per million for people aged 22-44 years). Incidence was greater among males; and Native Hawaiian/Pacific Islanders were more than 8 times more likely than whites to initiate treatment for ESRD, even after adjustment for age and gender.

Diabetes (180 per million population) and hypertension (112 per million population) were, by far, the most common assigned causes of incident ESRD.

 

 

Chart Explanation: 

Shown is the adjusted incidence of ESRD in 2018 in the United States by patient subgroup. As expected, the incidence rose dramatically with age (1,584 per million for people aged 75+ years compared to 139 per million for people aged 22 to 44 years). Incidence was higher in males (by >180 per million) than females. African-Americans were more than 2 times more likely than whites to initiate treatment for ESRD, while Native Hawaiian/Pacific Islanders were more than 8 times more likely than whites, and more than 3 times more likely than African-Americans to initiate treatment for ESRD. Patients with assigned ESRD causes of diabetes and hypertension had the highest incidence.

The United States Renal Data System (USRDS) is national registry of all patients treated for end-stage renal disease in the United States. It is sponsored by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and the Centers for Medicare & Medicaid Services (CMS) that reports prevalence of all treated ESRD in the United States. U.S. population denominators are determined through U.S. Census data. Tables from the USRDS annual report (United States Renal Data System, 2020) are publicly available for download.

FieldData
Description of MeasureIncidence of treated end-stage renal disease (ESRD) (stage 5)
Data SourceUSRDS (NIDDK/CMS)
Type of Data SourcePublic
Data SetUSRDS
Health Care System DataYes
Regional or National?National
Demographic GroupMedicare-eligible U.S. citizens with ESRD-related claims with known age, race/ethnicity, and gender
NumeratorNumber of patients with new diagnosis of ESRD
DenominatorU.S. resident population from U.S. census from corresponding year
Definition of CKDStage 5, <15 ml/min/1.73 m² with Medicare-eligibility for ESRD-related treatment
Primary Data Source IndicatorNumber of patients reported to have a new diagnosis of ESRD, as indicated by first treatment (dialysis or functioning transplant)
Primary Indicator Method of MeasurementClaims
Frequency of Measurement (Primary)Annual (cross-sectional)
U.S. Region Covered by Primary VariableAll
Period Currently Available

2018

Pending Data

2019

Additional Data Items of InterestYear, age (from date of birth), race/ethnicity (from Medicare 2728 form), gender (from Medicare 2728 form), assigned cause of ESRD (from Medicare 2728 form), body mass index (BMI)
Limitations of IndicatorOnly those who are Medicare-eligible are captured & eligibility may be delayed; changes in 2728 form
Analytic ConsiderationsDenominators change with missing stratification variables
Adjustment

Estimates are adjusted for age, race, and gender, as appropriate, using the 2015 ESRD cohort as reference.

References and Sources:

  • United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020.



Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd